NET PROFIT (x1000 EUR)
EMPLOYEES
Diabetesforbundet
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-244
|
0
|
-557 |
| Total assets |
1,470
|
2
|
2,393 |
| Current assets |
1,300
|
2
|
1,921 |
| Current liabilities |
433
|
0
|
682 |
| Equity capital |
729
|
1
|
1,325 |
| - share capital |
0
|
0
|
0 |
| Employees (average) |
19
|
26
|
33 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
49.6%
|
50.0%
|
55.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-16.6%
|
0%
|
-23.3% |
| Current ratio | 300.2% | 281.7% | |
| Return on equity (ROE) |
-33.5%
|
0%
|
-42.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
-7
|
-7
|
-8 |
| Chg. No. of employees % |
-27%
|
-21%
|
-20% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.